US Executive Officer Management Changes SEC — February 11, 2026

12-02-2026

Baxter International Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007474), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). Specific details including the officer's name, position, reason for change, timing, financial metrics, or quantitative data are NOT_DISCLOSED. No positive or negative performance metrics, period-over-period comparisons, or scheduled events are mentioned.

• ·Filing size: 1 MB
• ·Source: us_sec
• ·Sector: NOT_DISCLOSED

11-02-2026

Brag House Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001213900-26-015027), disclosing information under Item 5.02 regarding departure of directors or certain officers; election of directors; appointment of certain officers; or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or terms were provided in the filing summary. Sector not specified.

11-02-2026

RE/MAX Holdings, Inc. filed an 8-K on February 11, 2026 (AccNo: 0001104659-26-013546, Size: 185 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any financial or compensatory terms are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or governance impacts were provided in the available information.

11-02-2026

Peapack Gladstone Financial Corp filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

11-02-2026

Biogen Inc. filed a Form 8-K on 2026-02-11 disclosing an unspecified officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

Community Financial System, Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative impacts are disclosed.

11-02-2026

Tronox Holdings plc filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 8.01 covers other events and Item 9.01 lists financial statements and exhibits. Specific details including officer names, positions, reasons for change, or any quantitative data are NOT_DISCLOSED.

11-02-2026

USANA Health Sciences Inc filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons, timing, or quantitative data are disclosed.

11-02-2026

MARZETTI CO filed an 8-K on February 11, 2026, disclosing changes related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements under Item 5.02. Other events are reported under Item 8.01, with financial statements and exhibits under Item 9.01. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

11-02-2026

La Rosa Holdings Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed.

11-02-2026

Portillo's Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer's name, title, whether it is an appointment or resignation, reasons for the change, or any quantitative compensation data are disclosed. The filing appears routine with no mentioned positive or negative performance metrics tied to the change.

11-02-2026

AAR CORP filed an 8-K on February 11, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also covers Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on positions affected, names, reasons for change, quantitative data, or performance metrics are disclosed.

11-02-2026

Navan, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED.

11-02-2026

Cipher Mining Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, individual, or reasons provided. The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No quantitative metrics, performance comparisons, or further context on the change's implications are disclosed.

11-02-2026

BIO-TECHNE Corp filed an 8-K on 2026-02-11 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the key position affected, individual names, appointment/resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

11-02-2026

COMMUNITY HEALTH SYSTEMS INC filed an 8-K on February 11, 2026 (AccNo: 0001193125-26-046661), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including key positions affected, names of individuals, reasons for change, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material data points are provided in the available information.

11-02-2026

Bravo Multinational Inc. filed an 8-K on February 11, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals, reasons for change, or compensation are disclosed.

11-02-2026

Balance Labs, Inc. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included, but specific details on the affected position, appointment or resignation, reasons, or individuals involved are NOT_DISCLOSED. No quantitative metrics, performance comparisons, or additional corporate actions were mentioned.

11-02-2026

CNO Financial Group, Inc. filed an 8-K on 2026-02-11 disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on affected positions, names, appointment or resignation status, reasons, or any quantitative metrics are disclosed.

• ·Sector: sector not specified
• ·Filing Accession Number: 0001224608-26-000011
• ·Filing Size: 484 KB

11-02-2026

Mativ Holdings, Inc. filed an 8-K on 2026-02-11 disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details such as names, positions affected, reasons for change, or quantitative data are disclosed.

11-02-2026

Intuitive Machines, Inc. filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are explicitly stated. No positive or negative metrics, financial impacts, or scheduled events were mentioned.

11-02-2026

AEye, Inc. filed an 8-K on February 11, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed.

11-02-2026

Halliburton Co filed an 8-K on 2026-02-11 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, positions affected, reasons for change, effective dates, or quantitative details are disclosed in the provided filing summary. This appears to be a standard governance disclosure with no additional financial or operational metrics mentioned.

11-02-2026

Envoy Medical, Inc. filed an 8-K on 2026-02-11 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

11-02-2026

Star Gold Corp. filed an 8-K on February 11, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, individuals involved, reasons for the change, or any financial metrics are provided in the filing summary. Sector is not specified.

12-02-2026

Amrize Ltd filed a Form 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), names of individuals, reasons for the change, or any quantitative impacts are provided in the filing summary. No positive or negative metrics, financial data, or governance implications are mentioned.

12-02-2026

FTAI Aviation Ltd. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions, reasons for changes, timing, or quantitative details such as compensation amounts were provided. No positive or negative metrics, performance context, or governance implications were mentioned.

12-02-2026

AFFILIATED MANAGERS GROUP, INC. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-047590) under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including names, titles, reasons for changes, effective dates, or quantitative impacts are provided. No financial metrics, performance comparisons, or other operational data are mentioned.

12-02-2026

CarMax Inc filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Arvinas, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001628280-26-007463), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. This represents a standard disclosure requirement without additional context on positive or negative implications.

12-02-2026

DANA Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned in the provided filing information.

12-02-2026

FirstEnergy Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics are mentioned.

12-02-2026

EDAP TMS SA filed an 8-K on 2026-02-12 disclosing an officer change or related matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, whether it was an appointment or resignation, reasons for the change, or any quantitative financial impacts are disclosed. Item 7.01 suggests potential material non-public information was shared, but content is NOT_DISCLOSED.

12-02-2026

Bloomin' Brands, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names, reasons, or timing are NOT_DISCLOSED.

12-02-2026

Voyager Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, appointment or resignation, reasons, timing, or any quantitative data such as compensation amounts or share counts are disclosed. Sector is not specified.

12-02-2026

Evolv Technologies Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure in Item 7.01 and Financial Statements and Exhibits in Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Cue Biopharma, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any financial metrics are provided in the filing summary. This represents a standard governance disclosure with no quantified positive or negative impacts mentioned.

12-02-2026

Aardvark Therapeutics, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, whether it is an appointment or resignation, reasons for the change, named individuals, effective dates, or any quantitative data such as compensation amounts are disclosed. No financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Sprout Social, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001517375-26-000003), disclosing results of operations and financial condition under Item 2.02 alongside an officer change or related event under Item 5.02. Item 5.02 covers potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, but specific details including names, positions, reasons, and timing are NOT_DISCLOSED. No financial metrics, quantitative changes, or performance comparisons are provided in the available information.

12-02-2026

Sonoco Products Co filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-013958, Size: 226 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officers, positions, reasons for change, appointments, resignations, or any quantitative financial metrics are disclosed. The event is informational with no mentioned positive or negative performance indicators.

12-02-2026

Under Armour, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position affected, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Yum Brands Inc. filed an 8-K on February 12, 2026 (AccNo: 0001041061-26-000069), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, reasons for change, or any quantitative metrics such as compensation amounts are disclosed in the provided filing summary. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.

12-02-2026

FIRST US BANCSHARES, INC. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, timing, or any quantitative metrics are disclosed.

12-02-2026

TRANSUITE.ORG INC. filed a Form 8-K on 2026-02-12 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or any quantitative data are provided. No positive or negative metrics mentioned.

12-02-2026

Tennessee Valley Authority filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed in the provided filing information. No positive or negative performance metrics are mentioned.

12-02-2026

Pegasystems Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual involved, reason for change, or any quantitative metrics are disclosed.

12-02-2026

Verses AI Inc. filed an 8-K on 2026-02-12 disclosing officer changes or appointments under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on affected positions, names, reasons for change, or any quantitative metrics are provided. No positive or negative performance metrics mentioned.

12-02-2026

SPS COMMERCE INC filed an 8-K on 2026-02-12 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details regarding the officer change, including position affected, appointment or resignation status, reasons, timing, financial results, or any metrics are NOT_DISCLOSED. The filing size is 701 KB with AccNo 0001092699-26-000007.

12-02-2026

Kenvue Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are provided in the filing summary. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

• ·Filing Accession Number: 0000950157-26-000133
• ·File Size: 155 KB
• ·Sector: NOT_DISCLOSED

12-02-2026

Galera Therapeutics, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048696), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected, names of individuals, nature of change (appointment or resignation), reasons, and any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.

12-02-2026

Repay Holdings Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

12-02-2026

MASCO CORP /DE/ filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are provided in the filing summary. No positive or negative performance metrics, financial impacts, or further context are mentioned.

12-02-2026

Teladoc Health, Inc. filed an 8-K on February 12, 2026 (AccNo: 0001477449-26-000002), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

Edgemode, Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are provided.

12-02-2026

Rambus Inc filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

12-02-2026

Public Storage filed an 8-K on February 12, 2026, under Item 5.02 disclosing departure of directors or certain officers, election or appointment of directors/officers, or compensatory arrangements; Item 7.01 for Regulation FD disclosure; Item 8.01 for other events; and Item 9.01 for financial statements and exhibits. No specific details on the officer affected, position, appointment/resignation status, reasons, or any financial metrics are disclosed. This filing provides limited transparency on the leadership change event.

12-02-2026

Fortune Brands Innovations, Inc. filed an 8-K on February 12, 2026, reporting an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details including the key position affected, name of the officer, reason for change, appointment or resignation status, timing, and any financial metrics are NOT_DISCLOSED. No positive or negative metrics, scheduled events, or quantitative data are provided in the filing summary.

12-02-2026

Bain Capital GSS Investment Corp. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

Bright Horizons Family Solutions Inc. filed an 8-K on February 12, 2026, reporting results of operations and financial condition under Item 2.02 and officer departures, elections, appointments, or compensatory arrangements under Item 5.02. Financial statements and exhibits are provided under Item 9.01. No specific details on the officer change (e.g., position, reason, internal/external), financial metrics, or period-over-period comparisons are disclosed.

12-02-2026

NMI Holdings, Inc. filed an 8-K on February 12, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, appointment or resignation, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Ameriprise Financial Inc filed an 8-K on February 12, 2026 (AccNo: 0001104659-26-014312), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are provided. No quantitative metrics, performance comparisons, or other financial data are mentioned.

12-02-2026

Constellation Brands, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details regarding the key position affected, whether it is an appointment or resignation, reasons for the change, or any governance implications are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Norwegian Cruise Line Holdings Ltd. filed an 8-K on 2026-02-12 disclosing results of operations and financial condition under Item 2.02, an officer change or election/appointment under Item 5.02, and financial statements/exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, or financial metrics are provided in the filing summary. Sector not specified.

12-02-2026

The company filed an 8-K on 2026-02-12 (AccNo: 0001171843-26-000789) disclosing results of operations and financial condition under Item 2.02, an officer change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements under Item 5.02, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, quantitative data, executive names, reasons for the change, or performance details are provided. Event classified as Officer Change with no further elaboration.

12-02-2026

Grand Canyon Education, Inc. filed an 8-K on 2026-02-12 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Digimarc CORP filed an 8-K on February 12, 2026 (AccNo: 0001437749-26-003950), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, nature of the change (appointment or resignation), reasons, or timing are provided. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

12-02-2026

Childrens Place, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are disclosed.

12-02-2026

Equinix Inc filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data are disclosed.

12-02-2026

Celcuity Inc. filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also includes Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Specific details including names, positions, reasons, or compensation are NOT_DISCLOSED.

12-02-2026

Middlefield Banc Corp filed an 8-K on February 12, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.

12-02-2026

MVB Financial Corp filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, reason for change, or timing are disclosed.

12-02-2026

GEO Group Inc filed an 8-K on February 12, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. The filing also includes Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details such as names, titles, reasons for change, timing, or any quantitative data are disclosed.

12-02-2026

Keurig Dr Pepper Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals involved, reasons for change, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

12-02-2026

Republic Services, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), with no specific details on the officer, position, or reason provided. The filing also covers Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits), filed under AccNo: 0001060391-26-000066 (size: 540 KB). No quantitative metrics, financial impacts, or performance comparisons are mentioned.

• ·Filing AccNo: 0001060391-26-000066
• ·File Size: 540 KB
• ·Event Date: 2026-02-12
• ·Sector: NOT_DISCLOSED

12-02-2026

Titan International Inc filed an 8-K on February 12, 2026 (AccNo: 0000899751-26-000003), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer's name, position, reason for change, appointment or departure status, or any quantitative data are disclosed in the provided filing summary.

12-02-2026

Radian Group Inc filed an 8-K on February 12, 2026 (AccNo: 0001193125-26-048971), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for the change, or any quantitative data are explicitly stated. No positive or negative metrics, financial impacts, or governance implications are provided in the available information.

12-02-2026

Coeptis Therapeutics Holdings, Inc. filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the key position affected, individuals involved, reasons for change, timing, or any financial metrics are disclosed. No quantitative data or period-over-period comparisons provided.

12-02-2026

Limoneira CO filed an 8-K on 2026-02-12 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, individual names, appointment or resignation status, reasons, timing, or any quantitative data are disclosed.

12-02-2026

Lite Strategy, Inc. filed an 8-K on February 12, 2026, disclosing Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). Specific details including names, positions, reasons for changes, vote outcomes, or exhibit contents are NOT_DISCLOSED. No quantitative metrics, performance data, or directional implications are provided.